HIV Pre-exposure Prophylaxis (PrEP): A Survey of Dermatologists' Knowledge and Practice Patterns.

The article discusses effectiveness of treatment of human immunodeficiency virus (HIV) with pre-exposure prophylaxis (PrEP). It mentions that Sexually transmitted infections (STIs) often reflected on skin and are treated by dermatologist, discussed on the effect of Pre-exposure prophylaxis (PrEP) which uses antiretrovirals to prevent transmission and infection with HIV; and that PrEP with emtricitabine plus tenofovir disoproxil fumarate was approved by the US Food and Drug Administration (FDA).